SMS Pharmaceuticals Limited (NSEI: SMSPHARMA)
Health Care · Pharmaceuticals · IN
Rs356.60
-1.31% today · +52.1% 1Y
SMS Pharmaceuticals Limited (NSEI: SMSPHARMA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $349.04M and employs 1,197 people.
Over the last twelve months the share price has gained 52.1%, trading between 221.02 and 447.80.
Tweenvest scores SMS Pharmaceuticals Limited across four factors: quality 65/100, value 34/100, growth 45/100, dividend 38/100. Its strongest factor is quality.
SMSPHARMA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $349.04M
- Revenue (TTM)
- $94.95M
- P/E
- 32.29
- EPS
- 11.04
- Dividend yield
- 0.11%
- Beta (5Y)
- 0.34
- 52-week high
- Rs447.80
- 52-week low
- Rs221.02
- Avg volume (3M)
- —
- Shares outstanding
- 93.65M
- Employees
- 1,197
- Next earnings
- —
About SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited, an Indian company established in 1987 and based in Hyderabad, specializes in the production and distribution of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. The firm offers a wide array of APIs targeting various therapeutic categories, including anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, antiemetic, antiepileptic, antipsychotic, anti-hypertensive, anti-anginal, anti-viral, urinary antispasmodic, and anti-retroviral applications. Furthermore, SMS Pharmaceuticals engages in contract research activities and exports its products globally.
- ISIN
- INE812G01025
- Founded
- 1987
- Listed since
- Feb 28, 2007
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.